TAK
Takeda Pharmaceutical Co Ltd ADR
NYSE: TAK · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.68
+2.33% today
Updated 2026-04-30
Market cap
$52.70B
P/E ratio
75.82
P/S ratio
0.01x
EPS (TTM)
$0.22
Dividend yield
3.96%
52W range
$13 – $19
Volume
2.8M
Takeda Pharmaceutical Co Ltd ADR (TAK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $373.57B | $209.28B | $292.50B | $326.27B | $381.17B | $326.94B | $336.57B | $307.71B | $148.34B | $182.52B | $25.49B | $261.36B | $377.85B | $328.48B | $669.75B | $1.01T | $1.12T | $977.16B | $716.34B | $1.06T |
| Capital expenditures | $32.09B | $29.15B | $32.62B | $39.46B | $86.96B | $124.17B | $61.90B | $95.76B | $78.52B | $108.72B | $84.86B | $112.03B | $128.26B | $134.11B | $217.71B | $236.47B | $186.04B | $633.69B | $480.73B | $200.79B |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | $-213.78B | $20.35B | $14.71B | $17.41B | $18.61B | $20.08B | $29.12B | $37.66B | $43.37B | $60.67B | $70.87B | $72.87B |
| Free cash flow | $341.48B | $180.13B | $259.88B | $286.81B | $294.21B | $202.77B | $274.67B | $211.95B | $69.82B | $73.80B | $-59.37B | $149.34B | $249.59B | $194.37B | $452.04B | $774.46B | $937.07B | $343.47B | $235.61B | $856.39B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $85.53B | $98.76B | $129.17B | $142.45B | $143.55B | $142.06B | $142.01B | $142.12B | $142.13B | $141.64B | $141.54B | $141.69B | $141.89B | $142.95B | $282.58B | $283.36B | $283.67B | $279.42B | $287.19B | $302.50B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |